|
|
|
|
|
by lultimouomo
2281 days ago
|
|
> During the 2018 eastern Democratic Republic of the Congo outbreak, four investigational treatments were initially available to treat patients with confirmed Ebola. For two of those treatments, called regeneron (REGN-EB3) and mAb114, overall survival was much higher. These two antiviral drugs currently remain in use for patients with confirmed Ebola. How is this not a cure? If you mean that the cure doesn't save 100% of those who take it, than we have no cure for bacteria as well. |
|
It certainly does not appear that COVID-19 has a similar protocol, at which point we are in herpes territory of managing disease rather than curing it. I find it very strange that this is not being addressed.